rezafungin
FDA Approves Rezzayo, a Novel Echinocandin
Rezzayo, a novel echinocandin, is indicated for the treatment of candidemia and invasive candidiasis in adults 18.
MARCH 23, 2023
Rezafungin Receives Nod From FDA Antimicrobial Drugs Advisory Committee
In a 14-0 vote, the FDA’s Antimicrobial Drugs Advisory Committee recommended approval for rezafungin (Cidara ...
JANUARY 29, 2023
Load more